TMEM128 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.505800E-01
Normal-vs-Stage2
7.083800E-01
Normal-vs-Stage3
3.193700E-02
Normal-vs-Stage4
4.250000E-01
Stage1-vs-Stage2
1.154040E-01
Stage1-vs-Stage3
2.317900E-02
Stage1-vs-Stage4
1.865770E-01
Stage2-vs-Stage3
1.202820E-01
Stage2-vs-Stage4
8.491000E-01
Stage3-vs-Stage4
1.384980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.974200E-01
Normal-vs-AfricanAmerican
2.444800E-01
Normal-vs-Asian
6.355400E-01
Caucasian-vs-AfricanAmerican
3.963800E-01
Caucasian-vs-Asian
5.438000E-01
AfricanAmerican-vs-Asian
6.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.490800E-01
Normal-vs-Female
8.261200E-01
Male-vs-Female
2.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.978400E-01
Normal-vs-Age(41-60Yrs)
6.102000E-01
Normal-vs-Age(61-80Yrs)
3.153600E-01
Normal-vs-Age(81-100Yrs)
2.661800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.804800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.640000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.657800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.030000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.695600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.441800E-01
Normal-vs-Daily Drinker
9.990800E-01
Normal-vs-Weekly Drinker
3.044600E-01
Normal-vs-Occasional Drinker
6.133400E-01
Normal-vs-Social Drinker
6.537600E-01
Non Drinker-vs-Daily Drinker
3.564000E-01
Non Drinker-vs-Weekly Drinker
8.008600E-01
Non Drinker-vs-Occasional Drinker
5.895700E-02
Non Drinker-vs-Social Drinker
3.567800E-01
Daily Drinker-vs-Weekly Drinker
3.584000E-01
Daily Drinker-vs-Occasional Drinker
3.580400E-01
Daily Drinker-vs-Social Drinker
6.766200E-01
Weekly Drinker-vs-Occasional Drinker
9.843800E-02
Weekly Drinker-vs-Social Drinker
3.346400E-01
Occasional Drinker-vs-Social Drinker
8.849000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.661200E-01
Normal-vs-Grade 2
5.324400E-03
Normal-vs-Grade 3
1.935510E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.682800E-01
Grade 1-vs-Grade 3
7.910800E-01
Grade 1-vs-Grade 4
2.661200E-01
Grade 2-vs-Grade 3
1.048810E-01
Grade 2-vs-Grade 4
5.324400E-03
Grade 3-vs-Grade 4
1.935510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.444000E-01
Normal-vs-NonDiabetic
9.888600E-01
Diabetic-vs-NonDiabetic
9.715800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.705800E-01
Normal-vs-NoPancreatitis
6.315600E-01
Pancreatitis-vs-NoPancreatitis
8.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.306400E-01
Normal-vs-N1
7.303800E-01
N0-vs-N1
2.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.355600E-01
Normal-vs-TP53-NonMutant
9.007200E-01
TP53-Mutant-vs-TP53-NonMutant
5.666000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
